Innovative techniques for tissue engineering can have a tremendous impact on the future of the medical world. 3D bio-printing is a transformational technology holds great promise for the development of processes in the field of tissue engineering and regenerative medicine, and as a consequence, the future of medicine. Tissue engineering, regenerative medicine, and drug discovery require scaffolds and cells with precise geometry and pre-designed internal structure that can only be achieved with 3D bio-printing technology. The 3d-Bio group started its work in 2016, believing that it could build the future with the mix of the spirit of cooperation of specialists and cutting-edge solutions. Within a short period of time, the group has been able to gain a special place by offering four types of bio-printer devices with unique features, as well as providing special services in the field of tissue engineering and 3D printing.
3D bioprinting is an emerging technology used to design and rebuild 3D cellular constructs with the aim of replacing missing organs, drug screening and also cosmetics. The most striking advantage of this technology is its ability to create 3D structures with living biological components such as cells and their extracellular matrix.
In 3D bioprinting, the precise layer by layer placement of biological materials, biochemical cues and living cells with a similar structure to native tissues are used to create a three-dimensional construct. Researchers around the world are attempting to produce a 3D biological structure with appropriate biological and mechanical properties for lost tissues and organs substitution. One of the most important challenges is that this technology was previously used to print polymers and metals and now should be used to print biological, viable and sensitive materials. However, the ultimate goal of the research teams is to produce constructs that are very similar to the extracellular matrix in macrostructure and contain a suitable number and different types of cells.